Stress, Adjustment And Growth In Children With Cancer And Their Parents

This study examines the following outcomes:

• To examine outcomes of posttraumatic growth and benefit finding (PTG) in children with cancer/cancer survivors in comparison to a population of children without history of serious illness.
• To examine outcomes of posttraumatic stress (PTSS/PTSD) in children with cancer/cancer survivors in comparison to children without a history of serious illness.
• To examine predictors of child posttraumatic stress and posttraumatic growth from medical variables, life events history, family environment, and child personality variables.
• To apply an accelerated longitudinal design to examine trajectories of both pathological outcomes such as posttraumatic stress (PTSS) and positive outcomes such as challenge-related growth (CRG) in children with cancer/cancer survivors in comparison to a population of children without a history of serious illness. Additional observations will be obtained at 1-, 3-, and 5-years post study entry.
• To examine outcomes of PTG and PTSS/PTSD in parents of children with cancer/cancer survivors in comparison to parents of healthy children. Parental PTSS/PTSD and PTG will be examined both as outcomes and as predictors of child outcomes.
• To examine predictors of parent PTSS/PTSD and PTG from demographic and medical variables, life events history, and parent personality variables.
• To determine the sensitivity/specificity of measures of PTSS in screening for PTSD based on diagnostic interview.
• To examine the validity and reliability of a new measure of child personality, the Child and Adolescent Five Factor Inventory (CAFFI).
• To examine emerging social developmental outcomes in this longitudinal cohort.
• To develop an electronic version of the study measures and to compare data obtained electronically (on desktop or laptop computer), with data obtained on paper for comparability in reliability and outcomes obtained.

Inclusion criteria

Primary Group

• Research participant is 8-17 years inclusive
• Research participant has a primary diagnosis of malignancy
• Research participant is at least one month from diagnosis with no upper limit in terms of time elapsed since diagnosis;
• Research participant is able to speak and read English;
• Research participant does not have any significant cognitive or sensory deficits that would preclude participation;
• Parent/LAR and research participant is willing to participate and provide consent/assent

Young Child Group

• Research participant is 3 - 6 years of age, inclusive
• Primary diagnosis of malignancy
• At least one month from diagnosis
• One parent/LAR willing to participate and provide consent
• No history of sensory or developmental disorder that would invalidate study assessment procedures.

Young Adult Group

• Research participant is 18-25 years of age inclusive
• Primary diagnosis of malignancy
• At least one month from diagnosis with no upper limit in terms of time elapsed from diagnosis
• Able to read and speak English
• No cognitive or sensory deficits that would preclude participation
• Willing to participate and provide consent

Control Groups

• Research participant in 3 age groups (3 - 6 years; 8-17 years; 18-25 years) to match patient groups
• No history of chronic or life-threatening illness
• No cognitive or sensory impairment that would preclude completion of study measures
• Able to speak and read English
• Parent/LAR and research participant are willing to participate and provide informed consent/assent

Exclusions Criteria:NA